Patrick Oneill
Investor Relations and Capital Formation
Seattle, Washington
Overview
Work Experience
Investor Relations and Communications
2020 - Current
AI drug discovery platform.
Model Medicines uses human expertise and AI to accelerate the development of life-changing drugs at scale.
Raised $18,854,032.00 from Nex Cubed, 8VC, Irving Investors, TRITON FUNDS LLC, Particle Accelerator Limited (ParticleX), Carter Comstock and Friedman BioVentures.
Venture Partner: Investor Relations and Capital Formation
2013
Early-stage Venture Capital Manager.
Sway Ventures is a venture capital firm that invests in early to mid-stage technology companies.
Investor Relations and Capital Formation
2017 - 2024
Private Credit Manager.
Altriarch is an alternative investment platform focused on overlooked markets in underserved geographies, industries and market segments.
Raised $70,000,000.00 from State of Wisconsin Investment Board.
Marketing and Communications Consultant
2009 - 2023
6th Gen Single Family Office
Malloy & Company is a single family office.
Advisor: OCMO
2013 - 2016
Multifamily Office
Marketing and Capital Formation Consultant
2014 - 2016
A private investment firm focused on real estate and real estate-related opportunities across the United States.
Marketing and Capital Formation Consultant
2014 - 2016
European healthcare investment firm.
Marketing and Capital Formation Consultant
2013 - 2016
Alternative asset management firm focused on capital structure arbitrage and optionality.
Investor Marketing Consultant
2014 - 2015
Hedge fund with ESG integration as an alpha-generation tool.
Marketing and Capital Formation Consultant
2011 - 2012
Luxembourg-based private credit strategy focused on high-yielding instruments across the secured debt market.
Education
Bachelor’s Degree
2001 - 2005
Executive Summer Programme
2015 - 2015
Bachelor’s Degree
2003 - 2005
Master's degree
2009 - 2011